TEVA 3145 (Cephalexin Monohydrate 250 mg)
Pill with imprint TEVA 3145 is Gray / Orange, Capsule-shape and has been identified as Cephalexin Monohydrate 250 mg. It is supplied by Teva Pharmaceuticals USA.
Cephalexin is used in the treatment of bladder infection; bacterial infection; bacterial endocarditis prevention; bone infection; kidney infections and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Cephalexin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 3145
Cephalexin Monohydrate
- Imprint
- TEVA 3145
- Strength
- 250 mg
- Color
- Gray / Orange
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- First generation cephalosporins
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-3145
More about cephalexin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (462)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: first generation cephalosporins
Patient resources
- Drug Information
- Cephalexin (Advanced Reading)
- Cephalexin Capsules and Tablets
- Cephalexin Suspension
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.